Bayer halts sales of anti-bleeding drug
(AP)
<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20071106/ap_on_he_me/heart_drug"><img src="http://d.yimg.com/us.yimg.com/p/ap/20071105/capt.48739d43323148d3a3c35d6cdd4f9bc9.germany_trasylol_fra117.jpg?x=94&y=130&sig=2uCB0yuXDrlxrhY0YWh7xw--" align="left" height="130" width="94" alt="A bottle of the drug Trasylol by German pharma company Bayer is seen in a hospital in Dusseldorf, western Germany, Feb. 7, 2007. Drug maker Bayer AG said Monday, Nov. 5, 2007, that it has halted the global marketing of its anti bleeding drug Trasylol after a Canadian clinical study last month found that it could be linked to a higher risk of death than other drugs. (AP Photo/Roberto Pfeil)" border="0" /></a>AP - Bayer AG halted worldwide sales Monday of its anti-bleeding drug Trasylol at the request of U.S. and foreign health officials pending further analysis of a Canadian study that suggests it's linked to a 50 percent higher risk of death than the other drugs in the clinical trial.</p><br clear="all"/>

Read more...